Literature DB >> 9661591

Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.

T Carling1, J Rastad, G Akerström, G Westin.   

Abstract

Calcitriol, via its receptor (VDR) is a main regulator of PTH secretion and parathyroid cell proliferation. Recently, marked overrepresentation of the polymorphic VDR alleles b, a, and T was found in patients with primary hyperparathyroidism (pHPT), which suggests pathogenic importance in the disease. Using the ribonuclease protection assay, relative VDR and PTH messenger ribonucleic acid (mRNA) levels of parathyroid adenomas from 42 patients with sporadic pHPT were related to these VDR polymorphisms. The tumors of patients homozygous for the b, a, or T alleles demonstrated significantly lower VDR and higher PTH mRNA levels than those exhibiting the BB, AA, or tt genotypes (P < 0.0001-0.02), whereas heterozygotes had intermediate values. A similar discrepancy was found when comparing the baT and non-baT haplotypes (0.042 +/- 0.005 vs. 0.064 +/- 0.004 for VDR; 34.4 +/- 3.7 vs. 21.6 +/- 2.2 for PTH; both P < 0.005). The lower VDR mRNA levels associated with the b, a, and T alleles may affect the calcitriol-mediated control of parathyroid function and thereby contribute to the development of sporadic pHPT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661591     DOI: 10.1210/jcem.83.7.4862

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.

Authors:  Nicole Denzer; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

2.  BsmI-ApaI-TaqI TAC (BAt) Haplotype of Vitamin D Receptor Gene Is Associated with Increased Risk of Major Depressive Disorder.

Authors:  Munn-Sann Lye; Yin-Sim Tor; Yin-Yee Tey; Aishah Shahabudin; Su-Peng Loh; Normala Ibrahim; Johnson Stanslas; Rozita Rosli; King-Hwa Ling
Journal:  J Mol Neurosci       Date:  2020-10-09       Impact factor: 3.444

3.  Bone mass pharmacogenetics and ethnic health implications.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

4.  Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population.

Authors:  Zahra Mohammadnejad; Mohsen Ghanbari; Rashin Ganjali; Jalil Tavakkol Afshari; Mahyar Heydarpour; Seyed Morteza Taghavi; Sedigheh Fatemi; Houshang Rafatpanah
Journal:  Mol Biol Rep       Date:  2011-05-17       Impact factor: 2.316

5.  Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.

Authors:  P Selvaraj; S Prabhu Anand; M Harishankar; K Alagarasu
Journal:  J Clin Immunol       Date:  2009-02-14       Impact factor: 8.317

6.  Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis.

Authors:  P Selvaraj; M Vidyarani; K Alagarasu; S Prabhu Anand; P R Narayanan
Journal:  J Clin Immunol       Date:  2008-01-30       Impact factor: 8.317

7.  Vitamin D receptor haplotypes protect against development of colorectal cancer.

Authors:  Jana Flügge; Solveigh Krusekopf; Mark Goldammer; Elena Osswald; Werner Terhalle; Uwe Malzahn; Ivar Roots
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

Review 8.  Molecular genetics of parathyroid disease.

Authors:  Gunnar Westin; Peyman Björklund; Göran Akerström
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Renal stone disease, elevated iPTH level and normocalcemia.

Authors:  Nada B Dimkovic; Abdul Aziz Wallele; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 10.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.